EP1387692A4 - Molecular interactions in hematopoietic cells - Google Patents

Molecular interactions in hematopoietic cells

Info

Publication number
EP1387692A4
EP1387692A4 EP01987086A EP01987086A EP1387692A4 EP 1387692 A4 EP1387692 A4 EP 1387692A4 EP 01987086 A EP01987086 A EP 01987086A EP 01987086 A EP01987086 A EP 01987086A EP 1387692 A4 EP1387692 A4 EP 1387692A4
Authority
EP
European Patent Office
Prior art keywords
hematopoietic cells
molecular interactions
interactions
molecular
hematopoietic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01987086A
Other languages
German (de)
French (fr)
Other versions
EP1387692A2 (en
Inventor
Peter Lu
Joshua D Rabinowitz
Johannes Schweizer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arbor Vita Corp
Original Assignee
Arbor Vita Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arbor Vita Corp filed Critical Arbor Vita Corp
Publication of EP1387692A2 publication Critical patent/EP1387692A2/en
Publication of EP1387692A4 publication Critical patent/EP1387692A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5064—Endothelial cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP01987086A 2000-11-11 2001-11-09 Molecular interactions in hematopoietic cells Withdrawn EP1387692A4 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US724553 1996-09-30
US71005900A 2000-11-10 2000-11-10
US710059 2000-11-10
US72206900A 2000-11-24 2000-11-24
US72191500A 2000-11-24 2000-11-24
US721915 2000-11-24
US722069 2000-11-24
US72455300A 2000-11-28 2000-11-28
PCT/US2001/044138 WO2002042422A2 (en) 2000-11-10 2001-11-09 Molecular interactions in hematopoietic cells

Publications (2)

Publication Number Publication Date
EP1387692A2 EP1387692A2 (en) 2004-02-11
EP1387692A4 true EP1387692A4 (en) 2004-07-21

Family

ID=27505517

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01987086A Withdrawn EP1387692A4 (en) 2000-11-11 2001-11-09 Molecular interactions in hematopoietic cells

Country Status (3)

Country Link
EP (1) EP1387692A4 (en)
AU (1) AU2002239336A1 (en)
WO (1) WO2002042422A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6942981B1 (en) 1999-05-14 2005-09-13 Arbor Vita Corporation Method of determining interactions with PDZ-domain polypeptides
US20060100132A1 (en) * 2003-06-06 2006-05-11 Brit Corneliussen Method for diagnosing inflammatory bowel disease
US7410950B2 (en) 2004-04-01 2008-08-12 Board Of Regents, The University Of Texas System Peptides of CaV2.2 that inhibit pain
US9408381B2 (en) 2004-12-21 2016-08-09 Musc Foundation For Research Development Alpha Connexin c-Terminal (ACT) peptides for use in transplant
WO2006069181A2 (en) 2004-12-21 2006-06-29 Musc Foundation For Research Development Compositions and methods for promoting wound healing and tissue regeneration
AU2012202117B2 (en) * 2004-12-21 2014-06-26 Musc Foundation For Research Development Compositions and methods for promoting wound healing and tissue regeneration
US8633160B2 (en) 2005-12-30 2014-01-21 Nono Inc. Small molecule inhibitors of PDZ interactions
US9677042B2 (en) 2010-10-08 2017-06-13 Terumo Bct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
WO2013131040A1 (en) 2012-03-01 2013-09-06 Firststring Research, Inc. Topical gels containing alpha connexin c-terminal (act) peptides
US9617506B2 (en) 2013-11-16 2017-04-11 Terumo Bct, Inc. Expanding cells in a bioreactor
EP3613841B1 (en) 2014-03-25 2022-04-20 Terumo BCT, Inc. Passive replacement of media
CN107109410B (en) 2014-08-22 2021-11-02 奥克兰联合服务有限公司 Channel modulators
EP3198006B1 (en) 2014-09-26 2021-03-24 Terumo BCT, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP3656842A1 (en) 2017-03-31 2020-05-27 Terumo BCT, Inc. Cell expansion

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995008771A1 (en) * 1993-09-22 1995-03-30 Baxter Diagnostics Inc. Immobilization of chemically cross-linked proteins on solid supports

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995008771A1 (en) * 1993-09-22 1995-03-30 Baxter Diagnostics Inc. Immobilization of chemically cross-linked proteins on solid supports

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
GARDIOL D ET AL: "Oncogenic human papillomavirus E6 proteins target the discs large tumor suppressor for proteasome-mediated degradation", ONCOGENE, BASINGSTOKE, HANTS, GB, vol. 18, 1 September 1999 (1999-09-01), pages 5487 - 5496, XP002975936, ISSN: 0950-9232 *
GLAUNSINGER B A ET AL: "Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORFI and high-risk papillomavirus E6 oncoproteins", ONCOGENE, BASINGSTOKE, HANTS, GB, vol. 19, 1 November 2000 (2000-11-01), pages 5270 - 5280, XP002975937, ISSN: 0950-9232 *
KIYONO T ET AL: "Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosphila discs large tumor suppressor protein", JOURNAL OF BIOLOGICAL CHEMISTRY, AL, vol. 94, 1 October 1997 (1997-10-01), pages 11612 - 11616, XP002975938, ISSN: 0021-9258 *
LEE SIU SYLVIA ET AL: "Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, vol. 94, no. 13, 1 June 1997 (1997-06-01), pages 6670 - 6675, XP002207211, ISSN: 0027-8424 *
ROUSSET R ET AL: "The C-terminus of the HTLV-1 Tax oncoprotein mediates interaction with the PDZ domain of cellular proteins.", ONCOGENE 5 FEB 1998, vol. 16, no. 5, 5 February 1998 (1998-02-05), pages 643 - 654, XP002102450, ISSN: 0950-9232 *

Also Published As

Publication number Publication date
AU2002239336A1 (en) 2002-06-03
WO2002042422A2 (en) 2002-05-30
WO2002042422A3 (en) 2003-08-14
EP1387692A2 (en) 2004-02-11

Similar Documents

Publication Publication Date Title
EP1443951A4 (en) Molecular interactions in cells
EP1387692A4 (en) Molecular interactions in hematopoietic cells
AU7924501A (en) Progenitor cells and methods and uses related thereto
AU2126502A (en) Gene expression profiles in granulocytic cells
EP1289036A4 (en) Fuel cell
EP1276163A4 (en) Solid polymer fuel cell
GB0003231D0 (en) Cell culture media
SG86407A1 (en) Regenerative tie-high tie-low cell
AUPQ520600A0 (en) Improvements in electrolysis cells
AU2003281575A8 (en) Asynchronous messaging in storage area network
GB0006125D0 (en) Fuel cells
AU2002215354A1 (en) Molecular interactions in hematopoietic cells
AU4474401A (en) Fuel for use in fuel cell
GB0029625D0 (en) Electrochemical cells and their packaging
GB0229261D0 (en) Cells,culture methods and their uses
AU2001286809A1 (en) Genes expressed in the cell cycle
AU5011200A (en) Molecular interactions in hematopoietic cells
IL142951A0 (en) Improvements in methanol fuel cells
GB0020379D0 (en) Enzyme composition in tablet form
GB0004482D0 (en) Improvements in containers
GB0029957D0 (en) Improvements in storage volumes
AU2656801A (en) Improvements in electrolysis cells
HUP0202722A3 (en) Sequence-specific dna recombination in eukaryotic cells
GB0007324D0 (en) Cell culture
IL158702A0 (en) Improvements in methanol fuel cells

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030917

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20040604

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/50 20060101ALI20080507BHEP

Ipc: C07K 14/435 20060101ALI20080507BHEP

Ipc: C07K 14/15 20060101ALI20080507BHEP

Ipc: C07K 14/025 20060101AFI20080507BHEP

17Q First examination report despatched

Effective date: 20080915

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110601